Are you Dr. Marks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Howard Ave
Yale Physicians Bldg
New Haven, CT 06519Phone+1 203-785-2140Fax+1 203-785-6414- Is this information wrong?
Summary
- Dr. Peter Marks, MD is a hematologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut, New Jersey, and Massachusetts. He is an Associate Professor of Medicine at Yale University.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996
- Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1993
- New York University School of MedicineClass of 1991
Certifications & Licensure
- MA State Medical License 1992 - 2025
- NJ State Medical License 2004 - 2025
- CT State Medical License 2006 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2011
Publications & Presentations
PubMed
- 2 citationsClarifying US regulations on xenotransplantationPeter W. Marks, Steven M Solomon> ;Nature Biotechnology. 2021 Dec 2
- 1 citationsWhat regulators must learn from COVID-19.Peter W. Marks> ;Nature Medicine. 2021 Oct 28
- 8 citationsASH Research Collaborative: A Real-World Data Infrastructure to Support Real-World Evidence Development and Learning Healthcare Systems in Hematology.William A. Wood, Peter W. Marks, Robert M. Plovnick, Kathleen Hewitt, Donna Neuberg, Sam Walters, Brendan K. Dolan, Emily Tucker, Charles S. Abrams, Alexis A. Thompson...> ;Blood Advances. 2021 Oct 21
- Join now to see all
Press Mentions
- $3.5M Gene Therapy for Hemophilia Gets FDA ApprovalNovember 22nd, 2022
- FDA Approves First Gene Therapy for Hemophilia BNovember 22nd, 2022
- FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-cell LymphomaFebruary 5th, 2021
- Join now to see all
Professional Memberships
- Fellow